Horizons Wealth Management’s AbbVie ABBV Stock Holding History

Horizons Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.3K	Hold	52	–	–	0.01%	142
2025 Q4	$11.9K	Hold	52	–	–	0.01%	142
2025 Q3	$12K	Hold	52	–	–	0.01%	141
2025 Q2	$9.65K	Hold	52	–	–	0.01%	143
2025 Q1	$10.9K	Hold	52	–	–	0.01%	137
2024 Q4	$9.24K	Hold	52	–	–	0.01%	136
2024 Q3	$10.3K	Hold	52	–	–	0.01%	135
2024 Q2	$8.96K	Hold	52	–	–	0.01%	139
2024 Q1	$8.06K	Hold	52	–	–	0.01%	139
2023 Q4	$8.06K	Hold	52	–	–	0.01%	139
2023 Q3	$7.75K	Hold	52	–	–	0.01%	140
2023 Q2	$7.01K	Buy	52 +21	+68%	+$3.08K	0.01%	162
2023 Q1	$4.94K	Hold	31	–	–	﹤0.01%	138
2022 Q4	$5K	Hold	31	–	–	﹤0.01%	134
2022 Q3	$4K	Hold	31	–	–	﹤0.01%	134
2022 Q2	$4K	Buy	+31	New	+$4.74K	﹤0.01%	143

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Horizons Wealth Management's ABBV Position: Q1 2026 in Review

Horizons Wealth Management held its AbbVie (ABBV) position steady in Q1 2026 at 52 shares worth $11.3K. The position accounts for 0.01% of the portfolio, ranked #142.

Horizons Wealth Management first reported a position in ABBV in Q2 2022 and has held it in 16 quarters since. The position peaked at $12K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Horizons Wealth Management held 52 shares of AbbVie worth $11.3K as of Q1 2026.
Horizons Wealth Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.01% of Horizons Wealth Management's portfolio in Q1 2026, its #142 holding.
Horizons Wealth Management first reported a position in AbbVie in Q2 2022 and has held it in 16 quarters since.
Horizons Wealth Management's AbbVie position peaked at $12K in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Horizons Wealth Management's 13F filing for Q1 2026, filed 2 Apr 2026.